NXTS Launches AI Drug Initiative
Nexentis Technologies announces international AI drug discovery initiative with MitoCareX Bio and Boltz to accelerate novel SLC small-molecule discovery
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.